Progyny, Inc. to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
10 Novembro 2023 - 2:00PM
Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company
specializing in fertility and family building benefits solutions,
today announced that Pete Anevski, Progyny’s Chief Executive
Officer, and Mark Livingston, Chief Financial Officer, will
participate in a fireside chat at the Canaccord Genuity MedTech,
Diagnostics and Digital Health & Services Forum on Thursday,
November 16, 2023, at 10:30 A.M. Eastern Time.
A live audiocast and replay will be available from the Events
and Presentations section of Progyny’s website at
http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits
management company. We are redefining fertility and family building
benefits, proving that a comprehensive and inclusive solution can
simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with education and
guidance from a dedicated Patient Care Advocate (PCA), provides
access to a premier network of fertility specialists using the
latest science and technologies, reduces healthcare costs for the
nation’s leading employers, and drives optimal clinical outcomes.
We envision a world where anyone who wants to have a child can do
so.
Headquartered in New York City, Progyny has been recognized for
its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s
Best Places to Work in Healthcare, Financial Times, INC. 5000, and
Crain’s Fast 50 for NYC. For more information, visit
www.progyny.com.
For Further Information, Please Contact:
Investors:James Hartinvestors@progyny.com
Media:Selena Yangmedia@progyny.com
Progyny (NASDAQ:PGNY)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Progyny (NASDAQ:PGNY)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024